OverviewSuggest Edit

IntegraGen's mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in providing cutting edge genomic services to academic researchers and life sciences companies based on the Company's technological expertise and scientific know how.
TypePublic
Founded2000
HQÉvry, FR
Websiteintegragen.com

Latest Updates

Employees (est.) (Feb 2021)42
Share Price (Mar 2021)€2(-1%)
Cybersecurity ratingCMore

Key People/Management at IntegraGen

Bernard Courtieu

Bernard Courtieu

Chairman and Chief Executive Officer
Jean Stephenne

Jean Stephenne

Chairman
Laurence Riot Lamotte

Laurence Riot Lamotte

Chief Financial Officer
Bérengère Génin

Bérengère Génin

Director of Bioinformatics
Catherine David

Catherine David

Quality Director
Emmanuel Martin

Emmanuel Martin

Sales and Marketing Director, IntegraGen Genomics
Show more

IntegraGen Office Locations

IntegraGen has offices in Évry and Cambridge
Évry, FR (HQ)
5 Rue Henri Auguste Desbruères
Cambridge, MA, US
1 Mifflin Pl #400
Show all (2)

IntegraGen Financials and Metrics

IntegraGen Revenue

Market capitalization (30-Mar-2021)

12.9m

Closing stock price (30-Mar-2021)

2.0
IntegraGen's current market capitalization is €12.9 m.
Show all financial metrics

IntegraGen Cybersecurity Score

Cybersecurity ratingPremium dataset

C

72/100

SecurityScorecard logo

IntegraGen Online and Social Media Presence

Embed Graph

IntegraGen Blogs

Potential implication of urinary tract infections (UTIs) in bladder cancer development

Uropathogenic E.coli induces DNA damage in the bladder As provider of the whole genome sequencing, IntegraGen is proud of sharing this new publication. Background Urinary tract infections (UTIs) are caused by an uropathogenic strain of Escherichia coli that produce colibactin, a bacterial genotox…

New discoveries in DMD development open new perspectives for the disease diagnosis and therapeutics

Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset As provider of the bulk and single-cell RNA-seq libraries and sequencing, IntegraGen is proud of sharing this new publication. Background Duchenne Muscular Dystrophy (DMD) is a rare disease ch…

IntegraGen reports 2020 revenue of €9.0 million, an increase of +10%, and a cash position of €5.0 million as of December 31, 2020

IntegraGen announced today its unaudited business figures for the year 2020. 2020 revenue amounted to 9.0 M € versus 8.1 M € in 2019, an increase of 10% over 12 months. Increased sequencing services reported for company’s Evry lab and at outsourced platforms run by the company for the SeqOIA (…) (+…

IntegraGen Reports Results for 1st Half of 2020

IntegraGen has announced today its financial results for the first half of 2020 with the accounts having been reviewed by the Board of Directors on 17 September 2020. Company posts positive operating performance (EBITDA) for the second consecutive semester, supported by revenue growth (+5%) and  con…

COMMUNIQUE PROVIDING THE INFORMATION NOTE AND THE DOCUMENT “OTHER INFORMATION RELATING TO CHARACTERISTICS, IN PARTICULAR LEGAL, FINANCIAL AND ACCOUNTING” OF THE COMPANY ONCODNA S.A.

This press release was prepared and distributed by OncoDNA S.A. in accordance with the provisions of Articles 231-27 1 ° and 2 ° and 231-28 of the general regulations of the Autorité des marchés financiers (the “AMF”). (+) The post COMMUNIQUE PROVIDING THE INFORMATION NOTE AND THE DOCUMENT “OTHER IN…

COMBINED GENERAL ASSEMBLY

IntegraGen’s Combined General Assembly for 2020 will be held on September 17, 2020 at 2 p.m. at the company’s headquarters which is located at Génopole Campus 1,Genavenir 8, Porte 840, 5 rue Henri Desbruères – 91000 Evry, France Click here for more (…) (+) The post COMBINED GENERAL ASSEMBLY appeared…
Show more

IntegraGen Frequently Asked Questions

  • When was IntegraGen founded?

    IntegraGen was founded in 2000.

  • Who are IntegraGen key executives?

    IntegraGen's key executives are Bernard Courtieu, Jean Stephenne and Laurence Riot Lamotte.

  • How many employees does IntegraGen have?

    IntegraGen has 42 employees.

  • Who are IntegraGen competitors?

    Competitors of IntegraGen include Sysmex Inostics, Ajinomoto Althea and MorphoSys.

  • Where is IntegraGen headquarters?

    IntegraGen headquarters is located at 5 Rue Henri Auguste Desbruères, Évry.

  • Where are IntegraGen offices?

    IntegraGen has offices in Évry and Cambridge.

  • How many offices does IntegraGen have?

    IntegraGen has 2 offices.